R01 EY011766-12/EY/NEI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2008	2
2009	2
2024	0

Page 1

HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy.

Bartoli M, Al-Shabrawey M, Labazi M, Behzadian MA, Istanboli M, El-Remessy AB, Caldwell RW, Marcus DM, Caldwell RB. Bartoli M, et al. Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4934-40. doi: 10.1167/iovs.08-2158. Epub 2008 Dec 20. Invest Ophthalmol Vis Sci. 2009. PMID: 19098312 Free PMC article.

Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.

Al-Shabrawey M, Bartoli M, El-Remessy AB, Ma G, Matragoon S, Lemtalsi T, Caldwell RW, Caldwell RB. Al-Shabrawey M, et al. Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3231-8. doi: 10.1167/iovs.08-1754. Epub 2008 Mar 31. Invest Ophthalmol Vis Sci. 2008. PMID: 18378570 Free PMC article.

NAD(P)H oxidase-dependent regulation of CCL2 production during retinal inflammation.

Zhang W, Rojas M, Lilly B, Tsai NT, Lemtalsi T, Liou GI, Caldwell RW, Caldwell RB. Zhang W, et al. Invest Ophthalmol Vis Sci. 2009 Jun;50(6):3033-40. doi: 10.1167/iovs.08-2676. Epub 2009 Feb 21. Invest Ophthalmol Vis Sci. 2009. PMID: 19234337 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year